BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18799868)

  • 1. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
    de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
    Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
    Christmann RB; Wells AU; Capelozzi VL; Silver RM
    Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary manifestations of Sjögren's syndrome.
    Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
    Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
    Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
    Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
    Griffiths B; Miles S; Moss H; Robertson R; Veale D; Emery P
    J Rheumatol; 2002 Nov; 29(11):2371-8. PubMed ID: 12415594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
    Furuya Y; Kuwana M
    J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
    Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
    Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.
    Salaffi F; Di Carlo M; Carotti M; Fraticelli P; Gabrielli A; Giovagnoni A
    Radiol Med; 2018 Sep; 123(9):655-663. PubMed ID: 29687210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia.
    de Carvalho ME; Kairalla RA; Capelozzi VL; Deheinzelin D; do Nascimento Saldiva PH; de Carvalho CR
    Pathol Res Pract; 2002; 198(9):577-83. PubMed ID: 12440779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease.
    Moore OA; Proudman SM; Goh N; Corte TJ; Rouse H; Hennessy O; Morrisroe K; Thakkar V; Sahhar J; Roddy J; Youssef P; Gabbay E; Nash P; Zochling J; Stevens W; Nikpour M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S111-6. PubMed ID: 26243401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
    Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
    Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
    Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
    Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
    Desai SR; Veeraraghavan S; Hansell DM; Nikolakopolou A; Goh NS; Nicholson AG; Colby TV; Denton CP; Black CM; du Bois RM; Wells AU
    Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
    Pakas I; Ioannidis JP; Malagari K; Skopouli FN; Moutsopoulos HM; Vlachoyiannopoulos PG
    J Rheumatol; 2002 Feb; 29(2):298-304. PubMed ID: 11842824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.
    Fraticelli P; Gabrielli B; Pomponio G; Valentini G; Bosello S; Riboldi P; Gerosa M; Faggioli P; Giacomelli R; Del Papa N; Gerli R; Lunardi C; Bombardieri S; Malorni W; Corvetta A; Moroncini G; Gabrielli A;
    Arthritis Res Ther; 2014 Jul; 16(4):R144. PubMed ID: 25007944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma.
    Domiciano DS; Bonfá E; Borges CT; Kairalla RA; Capelozzi VL; Parra E; Christmann RB
    Clin Rheumatol; 2011 Feb; 30(2):223-9. PubMed ID: 20544245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
    Bosello SL; De Luca G; Rucco M; Berardi G; Falcione M; Danza FM; Pirronti T; Ferraccioli G
    Semin Arthritis Rheum; 2015 Feb; 44(4):428-36. PubMed ID: 25300701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
    Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
    Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.